UCLH and The Christie to host prestigious PTCOG conference 

28/07/2016 00:00 
The international Particle Therapy Co-Operative Group Annual Congress (PTCOG) will take place in 2019, in Manchester.
 

UCLH and The Christie NHS Foundation together with Marketing Manchester, are delighted to be hosting the prestigious Particle Therapy Co-Operative Group Annual Congress (PTCOG) in 2019, in Manchester.

This conference brings together more than 1,000 leading clinicians, physicists and other practitioners in particle therapy (a form of radiotherapy using beams of protons or heavy ions for cancer treatment) to share the latest clinical, scientific and industrial developments and showcase the latest technology which can enable organisations to improve patient treatment.

Professor Ranald Mackay, director of Christie medical physics & engineering and part of the project team bringing proton beam therapy to The Christie, said: “The Christie is very excited to be developing the national proton therapy service in partnership with UCLH. Our centre will open in 2018 and PTCOG in 2019 will bring the best clinicians and scientists from the particle therapy community to Manchester and ensure that the NHS service is world leading.”

Richard A. Amos, operational lead for proton therapy physics at UCLH and member of the organizing committee for PT COG added:  “PTCOG is the premiere international annual meeting for those involved in particle therapy treatment, research, and development. It’s a great honour to host this meeting here in the UK.”

Currently patients requiring proton beam therapy have to travel abroad for long periods of time to receive this state of the art treatment as the service is not available in the UK. These treatments will be delivered in Manchester and London as a national service combining the expertise of cancer specialists from the two hospitals.

The new service will bring together some of the world’s leading specialists in complex cancers.  Together, The Christie and UCLH will see more children and teenagers with cancer than almost any other centre in the world, and more adults with bone and soft tissue cancers and cancers of the skull base than any other centre in the UK.

The Christie, UCLH and  Marketing Manchester were supported by a host of organisations including the Kenes Group and the Clatterbridge Cancer Centre (who hosted PTCOG the last time it was in UK in 2003), and received supporting letters from the Secretary of State for Health, the Chief Executive of NHS England, the Royal College of Radiographers, CERN (European Organisation for Nuclear Research) and the National Physical Laboratory.

 Latest news

 Contact details

Communications unit
2nd floor central
250 Euston Road
London NW1 2PG

Media enquiries

Switchboard: 020 3456 7890
Media enquiries: 020 3447 7542 / 020 3447 9506
Email: uclh.media@nhs.net

Out of hours
The normal working hours for the Communications Unit are Monday to Friday 9am – 5pm. The only media enquiries that will be answered outside of these working hours are urgent enquiries and those relating to major incidents. To access the out-of-hours service call switchboard on 0845 155 5000.

Share this story